Donor-derived peripheral mononuclear cell DNA is associated with stable kidney allograft function a randomized controlled trial

Chimerism

Volumn 2, Issue 4, 2011, Pages 102-110

  Solgi, Ghasem ^a   Mytilineos, Joannis ^b   Gadi, Vijayakrishna ^c   Paul, Biswajit ^c   Pourmand, Gholamreza ^d   Mehrsai, Abdolrasoul ^d   Nikbin, Behrouz ^e   Amirzargar, Ali Akbar ^e  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c Fred Hutchinson Cancer Research Center   (United States)

^d Sina hospital   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Donor bone marrow infusion; Kidney allograft; Microchimerism

Indexed keywords

CELL DNA; HLA ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; CLINICAL ARTICLE; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; FEMALE; FLOW CYTOMETRY; GRAFT SURVIVAL; HUMAN; INTERMETHOD COMPARISON; KIDNEY TRANSPLANTATION; MALE; PATIENT MONITORING; PERIPHERAL BLOOD MONONUCLEAR CELL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 84855727292     PISSN: 19381956     EISSN: 19381964     Source Type: Journal    
DOI: 10.4161/chim.2.4.19095     Document Type: Article

References (34)

1. Starzl TE. Chimerism and tolerance in transplantation. Proc Natl Acad Sci USA 2004; 101:14607-14; PMID:15319473; http://dx.doi.org/10.1073/pnas.0404829101
2. Starzl TE. Acquired immunologic tolerance: with particular reference to transplantation. Immunol Res 2007; 38:6-41; PMID:17917005; http://dx.doi.org/10.1007/s12026-007-0001-7
3. Lechler RI, Garden OA, Turka LA. The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev Immunol 2003; 3:147-58; PMID:12563298; http://dx.doi.org/10.1038/nri1002
4. Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993; 17:1127-52; PMID:8514264; http://dx.doi.org/10.1002/hep.1840170629
5. McDaniel DO, Naftilan J, Hulvey K, Shaneyfelt S, Lemons JA, Lagoo-Deenadayalan S, et al. Peripheral blood chimerism in renal allograft recipients transfused with donor bone marrow. Transplantation 1994; 57:852-6; PMID:8154031; http://dx.doi.org/10.1097/00007890-199403270-00014
6. Fontes P, Rao AS, Demetris AJ, Zeevi A, Trucco M, Carroll P, et al. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart and pancreas islet transplantation. Lancet 1994; 344:151-5; PMID:7912764; http://dx.doi.org/10.1016/S0140-6736(94)92756-1
7. Ricordi C, Karatzas T, Selvaggi G, Nery J, Webb M, Fernandez H, et al. Multiple bone marrow infusions to enhance acceptance of allografts from the same donor. Ann NY Acad Sci 1995; 770:345-50; PMID:8597372; http://dx.doi.org/10.1111/j.1749-6632.1995.tb31066.x
8. Miller J, Mathew JM, Esquenazi V. Toward tolerance to human organ transplants: a few additional corollaries and questions. Transplantation 2004; 77:940-2; PMID:15077043; http://dx.doi.org/10.1097/01.TP.0000117781.50131.55
9. Mathew JM, Garcia-Morales R, Fuller L, Rosen A, Ciancio G, Burke GW, et al. Donor bone marrowderived chimeric cells present in renal transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses. Transplantation 2000; 70:1675-82; PMID:11152096; http://dx.doi.org/10.1097/00007890-200012270-00003
10. Ciancio G, Burke GW, Garcia-Morales R, Suzart K, Rosen A, Ricordi C, et al. Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients. Transplantation 2002; 74:488-96; PMID:12352907; http://dx.doi.org/10.1097/00007890-200208270-00010
11. Bonilla WV, Geuking MB, Aichele P, Ludewig B, Hengartner H, Zinkernagel RM. Microchimerism maintains deletion of the donor cell-specific CD8+ T cell repertoire. J Clin Invest 2006; 116:156-62; PMID:16395404; http://dx.doi.org/10.1172/JCI26565
12. Solgi G, Pourmand G, Mehrsai A, Taherimahmoudi M, Nicknam MH, Ebrahimi Rad MR, et al. Anti-HLA antibodies and kidney allograft outcomes in recipients with donor bone marrow cell infusion. Iran J Immunol 2010; 7:18-29; PMID:20371916
13. Millan MT, Shizuru JA, Hoffmann P, Dejbakhsh-Jones S, Scandling JD, Grumet FC, et al. Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation 2002; 73:1386-91; PMID:12023614; http://dx.doi.org/10.1097/00007890-200205150-00005
14. Spitzer TR, Delmonico F, Tolkoff-Rubin N, McAfee S, Sackstein R, Saidman S, et al. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 1999; 68:480-4; PMID:10480403; http://dx.doi.org/10.1097/00007890-199908270-00006
15. Strober S, Lowsky RJ, Shizuru JA, Scandling JD, Millan MT. Approaches to transplantation tolerance in humans. Transplantation 2004; 77:932-6; PMID:15077041; http://dx.doi.org/10.1097/01.TP.0000117782.93598.6E
16. Delis S, Ciancio G, Burke GW, 3rd, Garcia-Morales R, Miller J. Donor bone marrow transplantation: chimerism and tolerance. Transpl Immunol 2004; 13:105-15; PMID:15380541; http://dx.doi.org/10.1016/j.trim.2004.05.006
17. Rao AS, Fontes P, Zeevi A, Rugeles M, Shapiro R, Jordan M, et al. Enhancement of donor cell chimerism in whole organ allograft recipients by adjuvant bone marrow transplantation. Transplant Proc 1995; 27:3387-8; PMID:8540010
18. Monaco AP, Clark AW, Wood ML, Sahyoun AI, Codish SD, Brown RW. Possible active enhancement of a human cadaver renal allograft with antilymphocyte serum (ALS) and donor bone marrow: case report of an initial attempt. Surgery 1976; 79:384-92; PMID:769219
19. De Pauw L, Toungouz M, Goldman M. Infusion of donor-derived hematopoietic stem cells in organ transplantation: clinical data. Transplantation 2003; 75:46-9
20. Garcia-Morales R, Esquenazi V, Zucker K, Gomez CI, Fuller L, Carreno M, et al. An assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry. Transplantation 1996; 62:1149-60; PMID:8900317; http://dx.doi.org/10.1097/00007890-199610270-00021
21. Garcia-Morales R, Carreno M, Mathew J, Cirocco R, Zucker K, Ciancio G, et al. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients. Transplantation 1998; 65:956-65; PMID:9565101; http://dx.doi.org/10.1097/00007890-199804150-00016
22. De Pauw L, Abramowicz D, Donckier V, Kornreich A, Destrée M, Demoor F, et al. Isolation and infusion of donor CD34+ bone marrow cells in cadaver kidney transplantation. Nephrol Dial Transplant 1998; 13:34-6; PMID:9481712; http://dx.doi.org/10.1093/ndt/13.1.34
23. Solgi G, Amirzagar AA, Pourmand G, Mehrsai AR, Taherimahmoudi M, Baradaran N, et al. TH1/TH2cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion. Transplant Proc 2009; 41:2800-4; PMID:19765439; http://dx.doi.org/10.1016/j.transproceed.2009.07.053
24. Garcia-Morales R, Carreno M, Mathew J, Zucker K, Cirocco R, Ciancio G, et al. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients. J Clin Invest 1997; 99:1118-29; PMID:9062371; http://dx.doi.org/10.1172/JCI119240
25. Ciancio G, Miller J, Garcia-Morales RO, Carreno M, Burke GW, 3rd, Roth D, et al. Six-year clinical effect of donor bone marrow infusions in renal transplant patients. Transplantation 2001; 71:827-35; PMID:11349712; http://dx.doi.org/10.1097/00007890-200104150-00002
26. Pujal JM. Should microchimerism turn into rejection prophylactics? Expert Rev Mol Diagn 2010; 10:107-18; PMID:20014925; http://dx.doi.org/10.1586/erm.09.79
27. Hoerning A, Kalkavan H, Rehme C, Menke J, Worm K, Garritsen HS, et al. Quantitative real-time ARMSqPCR for mitochondrial DNA enables accurate detection of microchimerism in renal transplant recipients. Pediatr Transplant 2011; 15:809-18; PMID:21967552; http://dx.doi.org/10.1111/j.1399-3046.2011.01581.x
28. Starzl TE. Organ transplantation: a practical triumph and epistemologic collapse. Proc Am Philos Soc 2003; 147:226-45; PMID:14606490
29. Mathew JM, Miller J. Immunoregulatory role of chimerism in clinical organ transplantation. Bone Marrow Transplant 2001; 28:115-9; PMID:11509928; http://dx.doi.org/10.1038/sj.bmt.1703110
30. Mathew JM, Carreno M, Zucker K, Fuller L, Kenyon N, Esquenazi V, et al. Cellular immune responses of human cadaver donor bone marrow cells and their susceptibility to commonly used immunosuppressive drugs in transplantation. Transplantation 1998; 65:947-55; PMID:9565100; http://dx.doi.org/10.1097/00007890-199804150-00015
31. Adkins D, Johnston M, Walsh J, Spitzer G, Goodnough T. Hydroxyethylstarch sedimentation by gravity ex vivo for red cell reduction of granulocyte apheresis components. J Clin Apher 1998; 13:56-61; PMID:9704606; http://dx.doi.org/10.1002/(SICI)1098-1101(1998)13:256::AID-JCA23.0.CO;2-7
32. Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR. Single platform flowcytometric absolute CD34+ cell count based on ISHAGE guidline. Cytometery 1998; 34:61-70; http://dx.doi.org/10.1002/(SICI)1097-0320(19980415)34:261::AID-CYTO13.0.CO;2-F
33. Lambert NC, Lo YM, Erickson TD, Tylee TS, Guthrie KA, Furst DE, et al. Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer. Blood 2002; 100:2845-51; PMID:12351394; http://dx.doi.org/10.1182/blood-2002-01-0295
34. Lambert NC, Erickson TD, Yan Z, Pang JM, Guthrie KA, Furst DE, et al. Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma. Arthritis Rheum 2004; 50:906-14; PMID:15022334; http://dx.doi.org/10.1002/art.20200